Michael R. Bourque
Analyst · KBW
Thank you, Ron. Today on the call, I will review our financial results and then update you on our balance sheet and recent capital repurchase activity. Beginning with a review of our financial results for the second quarter 2014. Ocwen generated a total revenue of $553 million, which was flat from the first quarter 2014. Servicing revenue was $520 million and was also flat sequentially. Higher REO commissions and residential servicing fees offset the impact of a 3% decline in the unpaid principal balance. Lending revenue of $31 million increased 8% from the first quarter of 2014. During the quarter, Ocwen originated $1.2 billion of forward loans and $145 million of reverse loans. Total operating expenses for the company were $345 million, of which -- sorry, which was down 1% versus the first quarter and down 8% year-over-year. On a normalized basis, operating expenses would have been up $6.1 million or 2% versus the first quarter. As I will discuss later, total operating expenses included about $20.3 million of costs that we will eliminate in our normalization. Total other expense in the second quarter 2014 was $130 million, which was 100 -- which was 15% higher than the first quarter. The big driver was a $12.7 million increase in interest expense payable to HLSS, which I will explain further on our normalization page. The second impact was the increased interest expense from having a full quarter of the OASIS notes, as well as our new high-yield bond offering. Collectively, they added $5 million in interest expense in the quarter. As a result of these factors, we reported second quarter 2014 net income of $67 million, which was down 12% sequentially. From an EPS standpoint, our reported diluted net income per share was $0.48 in the quarter, a decrease of 11% versus the first quarter of 2014. Cash from operating activities was $14 million. Additionally, a normalized view of adjusted cash from operating activities, a non-GAAP measure we typically provide, was also $14 million in the quarter. The only normalization adjustment here is the impact of the $67 million payment we made as part of our National Mortgage Settlement. This cash generation level is lower than our historical levels, largely as a result of $118 million increase in loans held for sale in our lending business, which is largely driven -- which is largely timing driven and the result of increased volume late in the quarter as mortgage rates fell. Ocwen's total effective tax rate for the quarter was 13.2%. Our projected annual effective tax rate was largely unchanged between the first and second quarter. As we have said in the past, our rate varies depending on where our earnings are generated and the relative mix of operations in the mainland U.S. Consistent with comments made last quarter, we would expect our tax run rate to be in the low to mid-teens through the rest of the year. Touching on a few key results for the second quarter. Both our servicing and lending businesses performed well operationally, with our combined operating income up 8% versus the first quarter of 2014. Our operating expenses were down 1% in the quarter. We are pleased to see reductions in our transition-related expenses, as well as in our uncollectible receivable costs, which were $9 million lower than the $24 million charge we took in the first quarter of 2014. However, these favorable items were offset by a significant increase in compliance and regulatory-related costs, which were up significantly over last quarter. The biggest item was roughly $12 million of expenses for the New York state and national monitors. These costs are a significant element of our cost base. It is difficult to anticipate their future magnitude. I can tell you that we expect to incur roughly $9 million in the third quarter in ongoing monitoring costs, about $3 million lower than we saw in the second quarter. We believe costs will remain significant through the duration of the monitoring periods. Ocwen delivered $77 million in pretax earnings and $110 million in normalized pretax earnings. Normalized pretax earnings were down 7% versus the first quarter of 2014, driven by the cost elements I mentioned earlier. Additionally, interest expense was higher as a result of the recent high-yield bond and OASIS transaction. $33 million of normalized items were led by $19.3 million of MSR fair value related charges, $8.3 million of integration, technology and other costs, and finally a $5.4 million onetime increase in compensation expense for the surrender of options back in April. I will address these items in more detail later in the presentation. Finally, we returned cash to shareholders. In the quarter, we repurchased 2.6 million shares of stock for $92.3 million at an average price of $35.45. In July, we repurchased an additional 1.2 million shares for $43.9 million under our share repurchase program. We also repurchased over 1.9 million shares from funds managed by WL Ross & Co. after they converted their remaining 62,000 preferred shares into common shares. These repurchase activities returned over $200 million to shareholders since April 1 of the year. We are also pleased that Wilbur Ross will remain on our Board of Directors. I will now discuss our Servicing segment, which performed well in the quarter. In the second quarter, total revenue of $520 million was flat versus the first quarter 2014 and up 2% from $510 million in the second quarter last year. This included $357 million of servicing revenue and $31 million subservicing revenue. Servicing revenue was flat versus the first quarter of 2014. Higher REO sales and the recognition of the deferred servicing fees were offset by the impact of a 3% smaller unpaid principal balance. We collected $109 million of HAMP fees, late fees and other fees, which was flat compared to the first quarter of 2014. From the standpoint of servicing operating expense, we saw costs decline 3% from the first quarter of 2014. Turning to our portfolio at midyear. In total, Ocwen provided servicing or subservicing services for a total of approximately 2.7 million loans, with a total of UPB or unpaid principal balance of $435 billion. Total UPB is down 3% from March 31, 2014, due to loan runoff. As of June 30, 2014, approximately 80% -- 87% of the loans were performing and the remaining 13% were nonperforming. Compared with the first quarter of 2014, the nonperforming percent of the population has declined by 90 basis points. Largely consistent with last quarter, approximately 48% of the loans are conventional loans, 42% are non-agency and 10% is government insured. The total prepayment rate, or CPR, was approximately 12.9%, which was up 170 basis points from first quarter. CPR related to prime loans was 14.4%, compared to 12.6% in the first quarter, and CPR related to non-prime loans was 11.3%, compared to 9.2% in the first quarter. These higher prepayment speeds are driven by an increase in total debt payoffs and higher REO sales, which we expected given the weather-related delays we witnessed in the first quarter. We had another successful quarter of modification activity with around 27,500 modifications completed. The pace of our modifications remains healthy, with modification offers up through the second quarter after a significant decline in March. Also encouraging is that modification offers in July were at their highest levels so far this year. This should bode well for modification volumes in the second half. In the quarter, we continued our efforts to transfer the remaining loans off of the legacy ResCap system to real servicing, transferring a total of over 300,000 loans. We're currently working on the final system enhancements necessary to transfer the remaining 340,000 loans, of which 250,000 are Ginnie Mae related. We expect this to be completed before the end of the year, after which the ResCap portfolio would have been fully boarded and we can complete our integration and restructuring efforts. This may mean some previously communicated shutdown costs may fall in 2015 rather than 2014. We are working through the schedule and will provide an update with more certainty at the third quarter earnings release. While this is modestly behind the schedule we discussed earlier this year, it is important to note the our focus is always on quality and compliance, and we are willing to accept some delays in order to execute the transition effectively and efficiently. We will not sacrifice quality to accelerate the transfer. Next, we will move to discuss our lending segment, which improved from the first quarter of 2014. In the second quarter, total lending revenue of $31 million was up 8% from the first quarter and down 8% from the second quarter last year. The second quarter revenue included $22 million from gains on sales of loans and $9 million of other revenues. The 8% lending revenue growth over the first quarter was driven by our reverse lending business, where stronger margins more than offset the decline in unit volumes. The forward business originated $1.2 billion and 6,378 units. Unit volumes in our directed [ph] broker segments led to 2% year-over-year increase. The portion of our volume related to the HARP program is 39%, a decline of 17 points versus the first quarter of 2014, but still significantly above where we were in 2013. Lending operating expenses declined by 14% compared to the prior quarter and by 6% versus the second quarter of last year. This was driven by significant headcount reductions and cost efficiencies in both our forward and reverse platforms. The lending segment posted pretax income of $7 million in the second quarter compared to $600,000 in the first quarter, driven by higher margins and lower costs. At the end of the second quarter, we estimate that our reverse business had $37 million of pretax, unrecognized, future embedded value in its Ginnie Mae servicing portfolio discounted at 12%, primarily comprised of the value of anticipated future borrowings draws. From a strategic perspective, we're focusing our forward origination segment on improving service, speed and accuracy in all of the channels. We are also deepening the Lenders One partnership by improving service and executing on building a strong product development franchise focused on products that Bill spoke about in his portion of the presentation. Next, let me review our normalizing adjustments for the second quarter of 2014. As in the past, we provide a normalized pretax income, which adjusts for the impact of certain items in the quarter. The normalization is designed to give a clearer view of the ongoing operating performance of the business. During the second quarter of 2014, we incurred $33 million in normalized -- normalization expenses and delivered $110 million of pretax normalized income. These costs are best understood broken down into 3 areas: Fair value related changes, integration and transition costs and compensation expense. The first is $19.3 million of charges related to MSR fair value changes. We believe it is helpful to begin normalizing for MSR fair value related changes to offer more clarity into the underlying performance of the business, to present our results more consistently with some of the other non-bank servicers, and to more closely reflect how many stock analysts and investors evaluate our results. The $19.3 million charge is broken into 2 items. The first item is related to our sale of rights to MSRs to HLSS. In the second quarter, there was a $12.7 million increase in the fair value of the rights to MSRs sold to HLSS. This raised the value of the liability we recorded on our balance sheet, lowering principal amortization and increasing interest expense. It is worth noting that if our non-agency MSRs had been recorded at fair value instead of lower of cost to market, there would have been a similar valuation increase in our MSRs, which would have offset the income statement impacts on the increase in interest expense. I would note that this did not result in any change in the cash paid to HLSS. Mechanically, it meant the split of the cash payment made to HLSS would result in $12.7 million less of note payable principal amortization than expected and more interest expense. We've normalized for this item as it is a direct result of an MSR fair value change. On January 1, 2015, we have the opportunity to change our MSR accounting election from lower than cost or market to fair value in whole or from a part of the portfolio. Ocwen is the only large servicer that does not carry the majority of its MSRs at fair value. We are currently evaluating our position on fair value accounting. Second item in the quarter is the $6.6 million adjustment related to the fair value change on a small part of our portfolio that is carried at fair value. This is consistent with remarks you've seen in the past. The next area of normalizing expenses is also consistent with what you've seen Ocwen report under normalization in the past. In the quarter, there was $8.3 million of integration, technology-related and severance cost primarily associated with the ResCap acquisition integration. The final area of normalization relates to compensation expense, specifically, costs in connection with Mr. Erbey's voluntary surrender of stock options in April. Compensation expense in connection with option grants is based on the value of the option on the grant date, which is then recognized ratably as compensation expense for the term of the option grant. In event of a voluntary surrender where there isn't a concurrent grant or re-issue of options, the appropriate treatment is to expense immediately any remaining unrecognized stock option value. Apparently, this was designed to prevent companies from canceling out of the money option grants to avoid compensation costs. This clearly is not that type of situation, but nonetheless, we expensed the remaining $5.4 million unrecognized balance in the quarter. Now that we've covered the various elements impacting our income statement, we thought it will be helpful to reground [ph] everybody on the drivers of our 7% decline in normalized earnings versus the prior quarter. Operationally, we saw a solid business performance. The servicing business delivered flat revenue on a smaller UPB base, and our lending business was up significantly after a tough first quarter. Normalized operating expenses were up 2% in the quarter. We booked $15 million of additional reserves from collectible advances. This was $9 million below the $24 million we recorded in the first quarter of 2014. While this is favorable versus our first quarter performance, the reduction, frankly, is not as significant as we expected, and we have more work to do here to bring the ongoing costs back down to a more historical run rate. That is followed by the approximately $12 million increase in monitor cost we discussed earlier. Finally, you have the increase in interest expense, which is higher than the first quarter as a result of OASIS and high-yield bond transactions completed in the first half of the year. This leaves us with $110 million of normalized pretax income. Next, we will discuss the strength of the Ocwen balance sheet. At June 30, 2014, Ocwen had total assets of $8.4 billion. A unique element of the balance sheet is the fact that we have many transactions that count as financing versus true sales for accounting reasons. The impact of these transactions effectively grossed up the balance sheet. Additionally, we have advances that are financed and have offsets in liabilities. We believe it is instructive to consider our balance sheet without these factors, and by so doing, highlight our position as the best capitalized nonbank mortgage servicer in the industry. You can see a simplified reported balance sheet on the left side of the page. We have our advances, MSRs and other assets. In the liabilities section, we split it between match-funded liabilities, financing liabilities and other liabilities, then we have our equity. As we walk from left to right, we are adjusting both our assets and liabilities for financing transactions. For instance, we have about $2 billion of advances and also $2 billion of match-funded liabilities against those advances, so we removed them. We have roughly $1.1 billion of reverse mortgages that have effectively been sold. But the accounting rules say that we need to treat them as a financing, so we also have $1.1 billion of liabilities against that. Finally, we have the rights to MSRs that Ocwen has economically sold to HLSS with servicing retained. These are also treated as financing, and our assets largely match our liabilities here. The impact of all of these is to leave us with $4.7 billion of assets, $2.8 billion of liabilities and $1.9 billion of equity, representing a debt-to-equity ratio of 1.1:1. This is a high-quality balance sheet with a significant portion, roughly 30% investment-grade assets. Note that this value is lower than the 50% mentioned before, as some of the assets were sold in the previously mentioned transactions. It is still, however, a significant percentage. As we also discussed earlier, our MSRs are carried at lower of cost or market. We estimate this to be roughly $400 million below their current fair value, indicating a relatively conservative presentation of the asset. You will also note our MSR to tangible net worth ratio is now roughly 1:1. Finally, you can see that at these low levels, Ocwen has significant capital flexibility to support our growth initiatives, should we need it. Moving on to capital allocation. Our capital allocation strategy is unchanged from what we discussed back in 2013. Our priority is to first deploy capital to support the growth of our core servicing business. Our next priority is to deploy capital to expand into similar or complementary businesses with sustainable competitive advantages that enable us to meet our return hurdles. Absent opportunities in this area, we will then look to return cash to shareholders by repurchasing shares when we consider them to be attractively priced. In the fourth quarter of 2013, we announced our board approved a $500 million share repurchase program. And in February of this year, we communicated a general goal, but not obligation, to repurchase shares at least equal to the prior period earnings in the 3 months following our earnings announcements. During the second quarter, the company repurchased 2.6 million shares at an average price of $35.47 per share, representing an aggregate value of $92.3 million. In July, we repurchased an additional $43.9 million of stock at an average price per share of $36.15. This brings the amount of repurchases dating back to the time when we announced our share repurchase program to $198.5 million. This is above our combined fourth quarter '13 and first quarter '14 earnings. Additionally, we purchased 1.9 million shares upon the conversion of our convertible preferred stock in July, bringing the amount of cash returned to shareholders since we announced our share repurchase program to $271 million. Our repurchase goals remain unchanged, and as of today, we intend to continue to repurchase stock in the third quarter 2014. Thank you for joining us today. We would now be happy to take your questions. Jamie, if you can...